https://doi.org/10.5812/jjm.33990

NDM-1 and rmtC-Producing Klebsiella pneumoniae Isolates in Turkey

authors:

avatar Tulin Guven Gokmen 1 , * , avatar Togrul Nagiyev 2 , avatar Melda Meral 2 , avatar Cansu Onlen 2 , avatar Farzad Heydari 2 , avatar Fatih Koksal 2

Department of Microbiology, Ceyhan Veterinary Faculty, Cukurova University, Adana, Turkey
Department of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey
Jundishapur Journal of Microbiology: Vol.9, issue 10; e33990
published online: September 18, 2016
article type: Research Article
received: October 26, 2015
revised: August 15, 2016
accepted: August 23, 2016

how to cite: Guven Gokmen T, Nagiyev T, Meral M, Onlen C, Heydari F, et al. NDM-1 and rmtC-Producing Klebsiella pneumoniae Isolates in Turkey. Jundishapur J Microbiol. 2016;9(10):e33990. https://doi.org/10.5812/jjm.33990.

Abstract

Background:

The resistance of aminoglycosides in strains that produce beta-lactamase can be developed through the multidrug resistant encoding genes carried by common plasmids. Recently, the association between 16S rRNA methyltransferase resistance and beta-lactamase enzymes carried by the same plasmids has drawn increased attention from researchers, particularly the association in aminoglycoside-resistant strains with a minimum inhibitory concentration (MIC) of ≥ 256 µg/mL.

Objectives:

We aimed to investigate the co-existence of 16S rRNA methyltransferase and beta-lactamase genes in multidrug resistant (MDR) Klebsiella pneumoniae strains isolated from clinical samples.

Methods:

We determined the molecular mechanisms of aminoglycoside resistance and its relationship with resistance to carbapenem and beta-lactam group antibiotics in 40 extended-spectrum beta-lactamase (ESBL)-positive carbapenem- and aminoglycoside-resistant K. pneumoniae strains. Multidrug resistant K. pneumoniae was isolated from various clinical samples in the faculty of medicine of Cukurova University, Turkey. First, the resistance of aminoglycoside and beta-lactam antibiotics was phenotypically investigated using the Kirby-Bauer disk diffusion test, double disk synergy test, and modified Hodge test. The MIC values of aminoglycoside were determined using the agar dilution method. Polymerase chain reaction was performed to detect the carbapenemases, ESBL, and 16S rRNA methyltransferase genes. The results were confirmed by a sequence analysis.

Results:

Twenty K. pneumoniae strains showed resistance to amikacin, and 40 were resistant to gentamicin. The MIC value was found to be > 512 µg/mL in five amikacin-resistant strains and > 128 µg/mL in 10 gentamicin-resistant isolates. The rmtC gene, a type of 16S rRNA methyltransferase, was amplified in four isolates (MIC amikacin: > 512 µg/mL, gentamicin: > 128 µg/mL). Of these four isolates, three had the blaNDM-1 gene and all contained at least one ESBL gene.

Conclusions:

This study demonstrated the co-existence of rmtC and blaNDM-1 genes for the first time in Turkey. The spread of this resistant type should be monitored and limited through molecular surveillance.

1. Background

The resistance of major gram-negative bacteria, such as Escherichia coli and Klebsiella, against antibiotics of the beta-lactam group, especially carbapenem, is increasing. These bacteria isolated from infections in hospitals all over the world result in the failure of treatment (1).

The combined use of aminoglycoside and beta-lactam group antibiotics increases permeability by chelation of bacterial cell walls. However, a high level of resistance against aminoglycoside is evident in strains that are resistant to beta-lactam group antibiotics (2, 3). This high resistance needs to be investigated in detail, and the molecular mechanisms and epidemiological features of aminoglycoside resistance should be the focus. According to molecular studies conducted to determine the resistance mechanisms in bacteria against aminoglycoside, the following three mechanisms are responsible for the resistance: enzymes that modify aminoglycoside, mutation in genes that transport aminoglycoside, and alteration in ribosomal target proteins (4). A new resistance mechanism was discovered in 2003. This mechanism suggests that 16S rRNA methyltransferase genes are transported with plasmids and leads to a high level of resistance to aminoglycoside. This mechanism was demonstrated in Pseudomonas aeruginosa isolates in Japan and in Enterobacteriaceae isolates in France (5, 6). 16S rRNA methyltransferase was reported to significantly increase the level of aminoglycoside resistance by methylation of the G1405 residue (minimum inhibitory concentration [MIC] is typically ≥ 256 µg/mL) (7).

16S rRNA methyltransferase enzymes are generally seen together with carbapenemases and extended-spectrum beta-lactamase (ESBL). The existence of 16S rRNA methyltransferase has been observed in isolates carrying the genes blaNDM-1, blaKPC-2, blaVEB, blaTEM, blaCTX-M, blaSHV, and blaOXA. This outcome can be attributed to beta-lactamase and methyltransferase enzymes being located on the same plasmid (8-11).

2. Objectives

This study aimed to detect the co-existence of 16S rRNA methyltransferase enzymes and beta-lactamase genes in multidrug resistant (MDR) Klebsiella pneumoniae strains isolated from clinical samples in healthcare-associated infections.

3. Methods

A total of 228 clinical samples (i.e., blood, urine, bronchoalveolar lavage, sputum, and surgical wound) were collected from different clinics of the Medical Faculty of Balcali hospital at Cukurova University, Turkey, between August and December 2014. All the laboratory tests were performed at the laboratory of the Center and Medical microbiology department of the university. The samples were cultured on blood agar and Endo agar plates (Merck, Germany) at 37°C for 24 hours. The isolates were first evaluated by Gram staining to examine the morphology of colonies and biochemical test characteristics. Then, the bacterial species were identified using the VITEK-2 automated identification system (Biomerieux, Basingstoke, UK).

The resistance of beta-lactam antibiotics was investigated by the Kirby-Bauer disk diffusion (KBDD) test. The presence of ESBL was verified by the double disc synergy test, and carbapenem resistance was determined using the modified Hodge test. Escherichia coli ATCC 25922 was used as the control culture. To detect aminoglycoside resistance, amikacin (30 µg) and gentamicin (10 µg) sensitivities were examined through the KBDD test. Minimum inhibitory concentrations were determined by the agar dilution method on Mueller-Hinton agar plates according to the protocol recommended by the European committee on antimicrobial susceptibility testing (12).

In all isolates, DNA extraction was performed mechanically with a Mickle cell disruptor (The Mickle Lab. Engineering Co. Ltd., Gamshall, Surrey, UK). However, polymerase chain reaction (PCR) was performed only in isolates with an MIC value of > 512 μg/mL for amikacin and > 128 μg/mL for gentamicin to detect beta-lactamase genes and 16s rRNA methyltransferase genes. The multiplex PCR method was used to determine the presence of armA, npmA, rmtA, rmtB, rmtC, rmtD, rmtE, rmtF, rmtG, and rmtH genes (13). In addition, a type-specific multiplex PCR protocol was used to determine the carbapenemase and ESBL genes (Table 1) (14-16). The PCR products were separated on 1.5% agarose gel and monitored using a Kodak UV transilluminator (Kodak, New York, USA). A sequence analysis was performed using the dye terminator cycle sequencing method and the ABI Prism Big dye terminator kit (Applied Biosystems, Foster City, USA). The assay was conducted according to the manufacturer’s standard protocol. Data were collected on an ABI 310 automated fluorescence sequencer (Applied Biosystems). The types of 16S rRNA methyltransferase, carbapenemase, and ESBL genes were identified by comparing them with sequences from the GenBank database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). In all PCR procedures, distilled sterile water was used as the negative control. As no reference strains carrying rmtC were available, a positive control could not be used. Nevertheless, the sequences were verified by the DNA sequencing method.

Table 1.

PCR Primers Used in the Study (13, 14, 16)

Multiplex PrimersGeneForward/ReverseSequences (5’-3’)Product Size
TEM, SHV and OXA-1-likeTEMFCATTTCCGTGTCGCCCTTATTC800 bp
RCGTTCATCCATAGTTGCCTGAC
SHVFAGCCGCTTGAGCAAATTAAAC713 bp
RATCCCGCAGATAAATCACCAC
OXA-1 likeFGGCACCAGATTCAACTTTCAAG564 bp
RGACCCCAAGTTTCCTGTAAGTG
CTX-M group 1, group 2 and group 9CTX-M group 1FTTAGGAARTGTGCCGCTGYAb688 bp
RCGATATCGTTGGTGGTRCCATb
CTX-M group 2FCGTTAACGGCACGATGAC404 bp
RCGATATCGTTGGTGGTRCCATb
CTX-M group 9FTCAAGCCTGCCGATCTGGT561 bp
RTGATTCTCGCCGCTGAAG
CTX-M group 8/25CTX-M-8, 25,26,39,40,41FAACRCRCAGACGCTCTACb326 bp
RTCGAGCCGGAASGTGTYATb
VEB, PER and GESGESFAGTCGGCTAGACCGGAAAG399 bp
RTTTGTCCGTGCTCAGGAT
PERFGCTCCGATAATGAAAGCGT520 bp
RTTCGGCTTGACTCGGCTGA
VEBFCATTTCCCGATGCAAAGCGT648 bp
RCGAAGTTTCTTTGGACTCTG
SME,IMISMEFGAGGAAGACTTTGATGGGAGGAT334 bp
RTCCCCTCAGGACCGCCAAG
IMIFGGTGTCTACGCTTTAGACACTGGCTC536 bp
RGCACGAATACGCGCTGCACCGG
OXA-48-likeOXA-48-likeFGCTTGATCGCCCTCGATT281 bp
RGATTTGCTCCGTGGCCGAAA
IMP, VIM and KPCIMPFTTGACACTCCATTTACDGb139 bp
RGATYGAGAATTAAGCCACYCTb
VIMFGATGGTGTTTGGTCGCATA390 bp
RCGAATGCGCAGCACCAG
KPCFCATTCAAGGGCTTTCTTGCTGC538 bp
RACGACGGCATAGTCATTTGC
GIM-1,SIM-1, NDM-1 and SPM-1GIMFCGTTGCCAGCTTTAGCTCAGG279 bp
RGCAACTTGATACCAGCAGTGCG
SIMFTTGCGGAAGAAGCCCAGCCAG613 bp
RGCG TCT CCG ATT TCA CTG TGG C
NDMFCCC GGC CAC ACC AGT GAC A129 bp
RGTA GTG CTC AGT GTC GGC AT
SPMFGGG TGG CTA AGA CTA TGA AGC C447 bp
RGCC GCC GAG CTG AAT CGG
rmtA, rmtC, rmtD, rmtG, rmtHrmtAFAAACTATTCCGCATGGTTC88 bp
RTCATGTACACAAGCTCTTTCC
rmtCFCAGGGGTTCCAACAAGT246 bp
RAGAGTATATAGCTTGAACATAAGTAGA
rmtDFTCGTTTCAGCACGTAAAACA652 bp
RCAGCGCGAAATTCAAAAAGG
rmtGFACGGAATGCCGCGCGAAGTA381 bp
RTCTCCGCAAGCAGATCGCCG
rmtHFATGACCATTGAACAGGCAGC464 bp
RAGGGCAAAGGTAAAATCCCA
armA, npmA, rmtB, rmtE, rmtFarmAFATTTTAGATTTTGGTTGTGGC101 bp
RATCTCAGCTCTATCAATATCG
npmAFGGGCTATCTAATGTGGTG229 bp
RTTTTTATTTCCGCTTCTTCGT
rmtBFACTTTTACAATCCCTCAATAC171 bp
RAAGTATATAAGTTCTGTTCCG
rmtEFGATGCCGTGTCTGTTACGCCG446 bp
RACGTGAACCCACGAGTCCTGC
rmtFFCGATCCTACTGGGCTCCAT314 bp
RGGCATAGTGCTTTTCCATGC

4. Results

Forty isolates of K. pneumoniae were evaluated to determine the existence of and the relationship among carbapenemase, ESBL, and 16S rRNA methyltransferase genes. The strains were isolated from 4 blood, 15 urine, 7 bronchoalveolar lavage, 12 sputum, and 2 surgical wound samples. Twenty K. pneumoniae strains were resistant to amikacin, and 40 were resistant to gentamicin. The MIC values of amikacin and gentamicin were found to be > 512 µg/mL in five isolates and > 128 µg/mL in 10 isolates, respectively (Table 2).

Table 2.

Distribution of Amikacin and Gentamicin MIC Values Among the K. pneumoniae Isolates

Amikacin MIC Value, µg/mLNumber of IsolatesGentamicin MIC Value, µg/mLNumber of Isolates
> 5125> 12810
128512810
645644
321328
164162
--82
--44
Total20Total40

PCR was performed only on five isolates with an MIC value of > 512 μg/mL for amikacin and > 128 μg/mL for gentamicin. A specific DNA fragment with a length of 246 bp was amplified on the rmtC gene in four isolates with the above-mentioned MIC values. Of these four isolates, three contained the blaNDM-1gene and all were found to have at least one ESBL gene (Table 3). A sequence analysis was performed to confirm the PCR results.

Table 3.

Co-Existence of ESBL and 16S rRNA Methyltransferase Genes Among the K. pneumoniae Isolates (BAL: Bronchoalveolar Lavage)

IsolatesAmikacin MIC value, µg/mLGentamicin MIC Value, µg/mL16S Rrna Methyltransferase GeneCarbapenemase GenesESBL Genes
1 (Urine)> 512> 128rmtCNDM-1SHV
2 (Urine)> 512> 128rmtCNDM-1, OXA-48TEM,SHV
3 (Blood)> 512> 128rmtCOXA-48TEM
4 (BAL)> 512> 128rmtCNDM-1,OXA-48TEM,SHV
5 (BAL)> 512> 128-OXA-48SHV
rmtC-PCR Products
Lane 1, 50 bp DNA ladder; lane 4, sample 1; lane 7, sample 2; lane 13, sample 3; lane 16, sample 4 (246 bp); lane 9, negative control.

Lane 1, 50 bp DNA ladder; lane 4, sample 1; lane 7, sample 2; lane 13, sample 3; lane 16, sample 4 (246 bp); lane 9, negative control.

Figure 1.

rmtC-PCR Products

NDM-1-PCR Products
Lane 1, 100 bp DNA ladder; lane 2, negative control, lane 7, sample 1; lane 9, sample 2; lane 11, sample 4 (129 bp); lane 9, negative control.

Lane 1, 100 bp DNA ladder; lane 2, negative control, lane 7, sample 1; lane 9, sample 2; lane 11, sample 4 (129 bp); lane 9, negative control.

Figure 2.

NDM-1-PCR Products

TEM and SHV-PCR Products
Lane 5, 100 bp DNA ladder; lane 4, sample 1; lane 3, sample 2; lane 2, sample 3; lane 1, sample 4 (TEM: 800 bp, SHV: 713 bp).

Lane 5, 100 bp DNA ladder; lane 4, sample 1; lane 3, sample 2; lane 2, sample 3; lane 1, sample 4 (TEM: 800 bp, SHV: 713 bp).

Figure 3.

TEM and SHV-PCR Products

OXA-48-PCR Products
Lane 1, 100 bp DNA ladder; lane 2, sample 2; lane 3, sample 3; lane 4; sample 4; lane 5, sample 5; lane 6, negative control.

Lane 1, 100 bp DNA ladder; lane 2, sample 2; lane 3, sample 3; lane 4; sample 4; lane 5, sample 5; lane 6, negative control.

Figure 4.

OXA-48-PCR Products

5. Discussion

Combination antibiotic therapy has been shown to have synergistic effects in vitro and in vivo. This treatment alternative is usually preferred in clinics to prevent the development of resistance without requiring a toxic dose or widening the antibacterial spectrum (17). In particular, carbapenem and aminoglycoside are used in combination prior to colistin and tigecycline in the treatment of infections of Enterobacteriaceae isolates that produce carbapenemase. For example, the combinations of meropenem/imipenem and amikacin or doripenem and gentamicin have been suggested as an effective alternative treatment for K. pneumoniae strains that produce carbapenemase (18, 19).

In recent years, plasmids that transport ESBL and carbapenemase enzymes have been found to carry 16S rRNA methyltransferase aminoglycoside-resistant genes. Thus, aminoglycoside and beta-lactam antibiotic combinations are no longer considered clinically effective. This finding was verified by Wu et al., who detected the armA methyltransferase gene on a plasmid that codes the K. pneumoniae carbapenemase enzyme (20).

Despite having low prevalence in different types of bacteria, the 16S rRNA methyltransferase gene is globally spreading because of the plasmids that transport carbapenemase and ESBL genes among gram-negative bacilli. In Taiwan, the rmtB and armA genes were identified in E. coli and K. pneumoniae isolates with a high level of amikacin resistance, and the prevalence of armA was found to be higher than that of rmtB (7). In Japan, rmtA, rmtB, npmA, and armA were detected in gram-negative isolates with an amikacin MIC value of over 512 mg/L (21). In Korea, the co-existence of rmtE and CMY-2 cephalosporinase was reported (22). In China, armA and rmtB genes were found in gram-negative bacteria isolates with the amikacin MIC value being consistently over 512 mg/L (23).

In Saudi Arabia, the relationship between ESBL and 16S rRNA methyltransferase genes was investigated, and the rmtB, rmtC, and armA genes were detected in the same isolates (24). Fritsche et al. analyzed gram-negative bacteria isolates from North America, Latin America, and Europe and found that the armA, rmtB, and rmtD genes were resistant to aminoglycosides in isolates with amikacin MIC values of over 128 µg/L (25). The existence of the rmtF methyltransferase gene was reported in Nepal, the United States, India, and England (26). The rmtH gene was determined in a K. pneumoniae strain isolated from an American soldier who was wounded in Iraq in 2006 (27). In Turkey, the rmtB gene was shown in a K. pneumoniae isolate that was aminoglycoside resistant (28, 29). In another study, 16S rRNA methyltransferase resistance was not found in any of the 59 aminoglycoside-resistant clinical isolates that were evaluated over a five-year period (30).

In the current study, the rmtC gene was detected in four isolates with an MIC value of > 512 µg/mL for amikacin and > 128 µg/mL for gentamicin. We determined both NDM-1 and rmtC genes in three isolates with a high level of aminoglycoside resistance. We found at least one ESBL gene in all four isolates that contained the rmtC gene. The co-existence of the NDM-1 and rmtC genes was previously observed in K. pneumoniae strains isolated from clinical samples in Australia, Nepal, Kenya, and Bangladesh. However, to the best of our knowledge, this study is the first report conducted in Turkey showing the presence of the rmtC gene and the co-existence of NDM-1 and rmtC resistance genes among clinical isolates.

The combination of beta-lactam and aminoglycoside is an important treatment alternative for gram-negative bacterial infections, but it has lost its clinical significance because of 16S rRNA methyltransferase and other aminoglycoside-resistant mechanisms. 16S rRNA methyltransferase-type resistance has low prevalence but spreads easily in plasmids that transport beta-lactamase genes such as NDM-1. This resistance can spread across a wide geographic region in Turkey and in other parts of the world. Further studies are needed to determine the mechanisms of 16S rRNA methyltransferase and carbapenemase resistance. The spread of these types of resistances should be monitored using molecular analyses.

References

  • 1.

    Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60-7. [PubMed ID: 21653305]. https://doi.org/10.1093/cid/cir202.

  • 2.

    Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009;30(7):666-71. [PubMed ID: 19496647]. https://doi.org/10.1086/598244.

  • 3.

    Hu Y, Liu A, Vaudrey J, Vaiciunaite B, Moigboi C, McTavish SM, et al. Combinations of beta-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus. PLoS One. 2015;10(2):e0117664. [PubMed ID: 25692771]. https://doi.org/10.1371/journal.pone.0117664.

  • 4.

    Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updat. 2010;13(6):151-71. [PubMed ID: 20833577]. https://doi.org/10.1016/j.drup.2010.08.003.

  • 5.

    Yokoyama K, Doi Y, Yamane K, Kurokawa H, Shibata N, Shibayama K, et al. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet. 2003;362(9399):1888-93. [PubMed ID: 14667745]. https://doi.org/10.1016/S0140-6736(03)14959-8.

  • 6.

    Galimand M, Courvalin P, Lambert T. Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother. 2003;47(8):2565-71. [PubMed ID: 12878520].

  • 7.

    Doi Y, Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis. 2007;45(1):88-94. [PubMed ID: 17554708]. https://doi.org/10.1086/518605.

  • 8.

    Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P. Emergence of metallo-beta-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother. 2010;54(11):4914-6. [PubMed ID: 20823289]. https://doi.org/10.1128/AAC.00878-10.

  • 9.

    Quiles MG, Rocchetti TT, Fehlberg LC, Kusano EJ, Chebabo A, Pereira RM, et al. Unusual association of NDM-1 with KPC-2 and armA among Brazilian Enterobacteriaceae isolates. Braz J Med Biol Res. 2015;48(2):174-7. [PubMed ID: 25466163]. https://doi.org/10.1590/1414-431X20144154.

  • 10.

    Zhang Y, Zhou H, Shen XQ, Shen P, Yu YS, Li LJ. Plasmid-borne armA methylase gene, together with blaCTX-M-15 and blaTEM-1, in a Klebsiella oxytoca isolate from China. J Med Microbiol. 2008;57(Pt 10):1273-6. [PubMed ID: 18809557]. https://doi.org/10.1099/jmm.0.2008/001271-0.

  • 11.

    Hu F, Munoz-Price LS, DePascale D, Rivera JI, Doi Y. Klebsiella pneumoniae sequence type 11 isolate producing RmtG 16S rRNA methyltransferase from a patient in Miami, Florida. Antimicrob Agents Chemother. 2014;58(8):4980-1. [PubMed ID: 24841274]. https://doi.org/10.1128/AAC.02632-14.

  • 12.

    Breakpoint tables for interpretation of MICs and zone diameters. EUCAST website 2015; 2009. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_6.0_Breakpoint_table.pdf.

  • 13.

    Correa LL, Montezzi LF, Bonelli RR, Moreira BM, Picao RC. Revised and updated multiplex PCR targeting acquired 16S rRNA methyltransferases. Int J Antimicrob Agents. 2014;43(5):479-81. [PubMed ID: 24657046]. https://doi.org/10.1016/j.ijantimicag.2014.02.003.

  • 14.

    Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119-23. [PubMed ID: 21398074]. https://doi.org/10.1016/j.diagmicrobio.2010.12.002.

  • 15.

    Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490-5. [PubMed ID: 20071363]. https://doi.org/10.1093/jac/dkp498.

  • 16.

    Voets GM, Fluit AC, Scharringa J, Cohen Stuart J, Leverstein-van Hall MA. A set of multiplex PCRs for genotypic detection of extended-spectrum beta-lactamases, carbapenemases, plasmid-mediated AmpC beta-lactamases and OXA beta-lactamases. Int J Antimicrob Agents. 2011;37(4):356-9. [PubMed ID: 21353487]. https://doi.org/10.1016/j.ijantimicag.2011.01.005.

  • 17.

    Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev. 2012;25(3):450-70. [PubMed ID: 22763634]. https://doi.org/10.1128/CMR.05041-11.

  • 18.

    Le J, McKee B, Srisupha-Olarn W, Burgess DS. In vitro activity of carbapenems alone and in combination with amikacin against KPC-producing Klebsiella pneumoniae. J Clin Med Res. 2011;3(3):106-10. [PubMed ID: 21811540]. https://doi.org/10.4021/jocmr551w.

  • 19.

    Clancy CJ, Hao B, Shields RK, Chen L, Perlin DS, Kreiswirth BN, et al. Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes. Antimicrob Agents Chemother. 2014;58(6):3521-5. [PubMed ID: 24566172]. https://doi.org/10.1128/AAC.01949-13.

  • 20.

    Wu Q, Liu Q, Han L, Sun J, Ni Y. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem-resistant Enterobacter cloacae in China. Diagn Microbiol Infect Dis. 2010;66(3):326-8. [PubMed ID: 19903584]. https://doi.org/10.1016/j.diagmicrobio.2009.10.003.

  • 21.

    Yamane K, Wachino J, Suzuki S, Shibata N, Kato H, Shibayama K, et al. 16S rRNA methylase-producing, gram-negative pathogens, Japan. Emerg Infect Dis. 2007;13(4):642-6. [PubMed ID: 17553289]. https://doi.org/10.3201/eid1304.060501.

  • 22.

    Lee CS, Hu F, Rivera JI, Doi Y. Escherichia coli sequence type 354 coproducing CMY-2 cephalosporinase and RmtE 16S rRNA methyltransferase. Antimicrob Agents Chemother. 2014;58(7):4246-7. [PubMed ID: 24752254]. https://doi.org/10.1128/AAC.02627-14.

  • 23.

    Yang J, Ye L, Wang W, Luo Y, Zhang Y, Han L. Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates. Int J Antimicrob Agents. 2011;38(4):348-51. [PubMed ID: 21724374]. https://doi.org/10.1016/j.ijantimicag.2011.04.021.

  • 24.

    Al Sheikh YA, Marie MA, John J, Krishnappa LG, Dabwab KH. Prevalence of 16S rRNA methylase genes among beta-lactamase-producing Enterobacteriaceae clinical isolates in Saudi Arabia. Libyan J Med. 2014;9:24432. [PubMed ID: 25005152]. https://doi.org/10.3402/ljm.v9.24432.

  • 25.

    Fritsche TR, Castanheira M, Miller GH, Jones RN, Armstrong ES. Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America. Antimicrob Agents Chemother. 2008;52(5):1843-5. [PubMed ID: 18347105]. https://doi.org/10.1128/AAC.01477-07.

  • 26.

    Hidalgo L, Hopkins KL, Gutierrez B, Ovejero CM, Shukla S, Douthwaite S, et al. Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK. J Antimicrob Chemother. 2013;68(7):1543-50. [PubMed ID: 23580560]. https://doi.org/10.1093/jac/dkt078.

  • 27.

    O'Hara JA, McGann P, Snesrud EC, Clifford RJ, Waterman PE, Lesho EP, et al. Novel 16S rRNA methyltransferase RmtH produced by Klebsiella pneumoniae associated with war-related trauma. Antimicrob Agents Chemother. 2013;57(5):2413-6. [PubMed ID: 23478957]. https://doi.org/10.1128/AAC.00266-13.

  • 28.

    Ermertcan S, Yilmaz FF, Taşli H, Yurtman AN, Aydemir SS, Limoncu MH. Investigation of plasmid mediated methylase genes in aminoglycoside resistant gram negative bacteria. Türk Mikrobiyol Cem Derg. 2013;43(1):12-6. https://doi.org/10.5222/TMCD.2013.012.

  • 29.

    Ermertcan S, Hoşgör Limoncu M, Taşlı H, Eraç B, Gazi H. Gram negatif bakterilerde plazmid aracılı yüksek düzey aminoglikozit direncinin araştırılması. İnfeks Derg. 2008;22:203-7.

  • 30.

    Bercot B, Poirel L, Ozdamar M, Hakko E, Turkoglu S, Nordmann P. Low prevalence of 16S methylases among extended-spectrum-beta-lactamase-producing Enterobacteriaceae from a Turkish hospital. J Antimicrob Chemother. 2010;65(4):797-8. [PubMed ID: 20093261]. https://doi.org/10.1093/jac/dkq003.